Clinical Trial Update: Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating two guided transfusion strategies and their effect on blood product usage in liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrin Blood Clot
• Liver Transplantation

Snippet

Sponsor: Antoni Sabaté Pes | Conditions: Fibrin Blood Clot | Phase 4 | Status: UNKNOWN